1. Impact of COVID-19 vaccination on mortality after acute myocardial infarction.
- Author
-
Gupta MD, Kunal S, M P G, Goyal D, Malhotra RK, Mishra P, Shukla M, Gupta A, Kohli V, Bundela N, Batra V, Bansal A, Yadav R, Yusuf J, and Mukhopadhyay S
- Subjects
- Humans, COVID-19 Vaccines adverse effects, Propensity Score, Retrospective Studies, Vaccination, COVID-19, Myocardial Infarction
- Abstract
Background: COVID-19 vaccines are highly immunogenic but cardiovascular effects of these vaccines have not been properly elucidated., Objectives: To determine impact of COVID-19 vaccination on mortality following acute myocardial infarction (AMI)., Methods: This was a single center retrospective observation study among patients with AMI enrolled in the the North India ST-Elevation Myocardial Infarction (NORIN-STEMI) registry. In all the enrolled patients, data regarding patient's vaccination status including details on type of vaccine, date of vaccination and adverse effects were obtained. All enrolled subjects were followed up for a period of six months. The primary outcome of the study was all-cause mortality both at one month and at six months of follow-up. Propensity-weighted score logistic regression model using inverse probability of treatment weighting was used to determine the impact of vaccination status on all-cause mortality., Results: A total of 1578 subjects were enrolled in the study of whom 1086(68.8%) were vaccinated against COVID-19 while 492(31.2%) were unvaccinated. Analysis of the temporal trends of occurrence of AMI post vaccination did not show a specific clustering of AMI at any particular time. On 30-day follow-up, all-cause mortality occurred in 201(12.7%) patients with adjusted odds of mortality being significantly lower in vaccinated group (adjusted odds ratio[aOR]: 0.58, 95% CI: 0.47-0.71). Similarly, at six months of follow-up, vaccinated AMI group had lower odds of mortality(aOR: 0.54, 95% CI: 0.44 to 0.65) as compared to non-vaccinated group., Conclusions: COVID-19 vaccines have shown to decrease all-cause mortality at 30 days and six months following AMI., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2023 Gupta et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF